PTCT
PTC Therapeutics, Inc. · Healthcare · Biotechnology
Input momentum (manajer yang sebanding):
keluasan pemegang +10.0% ·
aliran saham +3.1% ·
posisi baru bersih +9.1%
· formula
Akumulasi luas: saham yang meningkat di lebih banyak pemegang
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q3 2025
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | 0 | 18.67K | $1.18M | n/a | n/a |
| Q2 2026 | 113 | +8 | 59.00M | $4.80B | +13 | −7 |
| Q1 2026 | 110 | -8 | 65.31M | $4.45B | +9 | −18 |
| Q4 2025 | 117 | 0 | 67.93M | $5.16B | +1 | n/a |
| Q3 2025 | 22 | +2 | 38.04M | $2.33B | +2 | n/a |
| Q2 2025 | 17 | 0 | 34.63M | $1.69B | +1 | −1 |
| Q1 2025 | 14 | +2 | 16.93M | $862.87M | +2 | n/a |
| Q4 2024 | 12 | 0 | 14.84M | $670.12M | n/a | n/a |
| Q3 2024 | 11 | -2 | 14.00M | $519.42M | n/a | −2 |
| Q2 2024 | 13 | n/a | 14.28M | $436.54M | n/a | n/a |
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (pasif) | 8.29M | -6.3% | $508.70M | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 2 | BlackRock ✦ (pasif) | 7.13M | -4.7% | $437.62M | 0.0% | ▼ Trim | 2 | SEC ↗ ×18 |
| 3 | Wellington Management ✦ | 4.92M | +4.8% | $301.86M | 0.1% | ▲ Add | 6 | SEC ↗ ×8 |
| 4 | State Street Global Advisors ✦ (pasif) | 3.13M | +4.6% | $192.38M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 5 | D. E. Shaw & Co. ✦ | 2.17M | -10.8% | $133.46M | 0.1% | ▼ Trim | 6 | SEC ↗ ×3 |
| 6 | Geode Capital Management ✦ (pasif) | 1.95M | +0.8% | $119.74M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 7 | Citadel Advisors ✦ | 1.73M | +88.0% | $106.23M | 0.1% | ▲ Add | 6 | SEC ↗ ×2 |
| 8 | Fidelity (FMR) ✦ | 1.61M | -6.2% | $98.91M | 0.0% | ▼ Trim | 2 | SEC ↗ ×4 |
| 9 | Point72 Asset Management ✦ | 1.22M | Baru | $74.91M | 0.2% | New | 1 | SEC ↗ |
| 10 | Millennium Management ✦ | 1.06M | +174.8% | $64.84M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 11 | JPMorgan Chase ✦ | 981.87K | n/a | $60.26M | 0.0% | n/c | 1 | SEC ↗ ×18 |
| 12 | Renaissance Technologies ✦ | 927.30K | -3.7% | $56.91M | 0.1% | ▼ Trim | 6 | SEC ↗ |
| 13 | Goldman Sachs Group ✦ | 876.41K | n/a | $53.79M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 14 | T. Rowe Price ✦ | 458.33K | +1.0% | $28.13M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 15 | Morgan Stanley ✦ | 419.42K | n/a | $25.74M | 0.0% | n/c | 1 | SEC ↗ ×7 |
| 16 | AQR Capital Management ✦ | 331.26K | -38.3% | $20.33M | 0.0% | ▼ Trim | 6 | SEC ↗ ×4 |
| 17 | Arrowstreet Capital ✦ | 323.55K | +851.6% | $19.86M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 18 | Adage Capital Partners ✦ | 291.00K | -52.0% | $17.86M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 19 | Marshall Wace ✦ | 157.74K | -70.7% | $9.68M | 0.0% | ▼ Trim | 3 | SEC ↗ ×2 |
| 20 | Two Sigma Investments ✦ | 24.34K | -52.1% | $1.49M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 21 | Gotham Asset Management ✦ | 18.06K | -49.3% | $1.11M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 22 | Bridgewater Associates ✦ | 11.94K | Baru | $732,635 | 0.0% | New | 1 | SEC ↗ |
"Their weight" = porsi posisi dari nilai ekuitas 13F yang dilaporkan manajer tersebut: ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Point72 Asset Management | $74.91M | 0.2% |
| Bridgewater Associates | $732,635 | 0.0% |
Telah keluar
| Tidak ada keluar yang terlacak kuartal ini. |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 348 pemegang, 95.15M saham, $6.33B dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Apa lagi yang paling sering dimiliki oleh pemegang sekuritas ini yang dilacak: jumlah kepemilikan bersama, bukan hubungan fundamental.
Pembelian di pasar terbuka (P)
Tidak ada pembelian insider di pasar terbuka dalam jendela cakupan kami.
Penjualan di pasar terbuka (S)
Director · 382 lbr · $22,973
Director · 2.12K lbr · $126,063
Officer · 192 lbr · $12,338
Director · 2.45K lbr · $155,091
Director · 53 lbr · $3,389
Officer · 435 lbr · $27,910
Officer · 1.64K lbr · $104,881
Director · 376 lbr · $25,737
Director · 9.62K lbr · $652,796
Director · 7.01K lbr · $471,854
Penghargaan, eksekusi, dan pemotongan pajak tidak pernah dihitung sebagai pembelian atau penjualan di sini. Metodologi